Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction

American Journal of Cardiology

Volumn 94, Issue 4, 2004, Pages 448-453

  Takeda, Yutaka ^a,c   Fukutomi, Tatsuya ^a   Suzuki, Shogo ^b   Yamamoto, Koji ^b   Ogata, Masaki ^a   Kondo, Hiroaki ^a   Sugiura, Masato ^a   Shigeyama, Junsho ^a   Itoh, Makoto ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b CHUBU NATIONAL HOSPITAL   (Japan)

^c Mizuho ku 467 8601 ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; VALSARTAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; EXERCISE; FEMALE; GENERAL CONDITION IMPROVEMENT; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MULTIVARIATE ANALYSIS; PATIENT; PHYSICAL CAPACITY; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; REGRESSION ANALYSIS; SYMPTOMATOLOGY;

ACTIVITIES OF DAILY LIVING; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBAZOLES; CARDIAC OUTPUT, LOW; DIGITALIS GLYCOSIDES; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROPANOLAMINES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 4344586997     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.05.004     Document Type: Article

References (25)

1. Aronow W.S., Ahn C., Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol. 66:1990;1257-1259
2. Davie A.P., Francis C.M., Caruana L., Sutherland G.R., McMurray J.J. The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure. Eur Heart J. 18:1997;981-984
3. Dougherty A.H., Naccarelli G.V., Gray E.L., Hicks C.H., Goldstein R.A. Congestive heart failure with normal systolic function. Am J Cardiol. 54:1984;778-782
4. Iriarte M., Murga N., Sagastagoitia D., Molinero E., Morillas M., Salcedo A., Estella P., Etxebeste J. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. Am J Cardiol. 71:1993;308-312
5. Litwin S.E., Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol. 22:1993;49A-55A
6. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldmanmd A.M., Francis G.S., Ganiats T.G., Goldstein S., Gregoratos G., Jessup M.L., et al. American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to revise the 1995 guidelines for the evaluation, management of heart failure); International Society for Heart, Lung Transplantation; Heart Failure Society of America. ACC/AHA guidelines for the evaluation, management of chronic heart failure in the adult executive summary A. Report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation. 104:2001;2996-3007
7. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology, Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 22:2001;1527-1560
8. Aronow W.S., Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol. 71:1993;602-604
9. Setaro J.F., Zaret B.L., Schulman D.S., Black H.R., Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol. 66:1990;981-986
10. Warner J.G. Jr, Metzger D.C., Kitzman D.W., Wesley D.J., Little W.C. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol. 33:1999;1567-1572
11. Stanek B., Frey B., Hulsmann M., Berger R., Sturm B., Strametz-Juranek J., Bergler-Klein J., Moser P., Bojic A., Hartter E., Pacher R. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol. 38:2001;436-442
12. Kawai K., Hata K., Takaoka H., Kawai H., Yokoyama M. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy a potential of hormone-guided treatment. Am Heart J. 141:2001;925-932
13. Hara Y., Hamada M., Shigematsu Y., Suzuki M., Kodama K., Kuwahara T., Hashida H., Ikeda S., Ohtsuka T., Hiasa G., Hiwada K. Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Jpn Circ J. 64:2000;365-369
14. Fujimura M., Yasumura Y., Ishida Y., Nakatani S., Komamura K., Yamagishi M., Miyatake K. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy. J Card Fail. 6:2000;3-10
15. Goldman L., Hashimoto B., Cook E.F., Loscalzo A. Comparative reproductively and validity of systems for assessing cardiovascular function class advantages of a new specific activity scale. Circulation. 64:1981;1227-1234
16. Cheitlin M.D., Alpert J.S., Armstrong W.F., Aurigemma G.P., Beller G.A., Bierman F.Z., Davidson T.W., Davis J.L., Douglas P.S., Gillam L.D. ACC/AHA guide-lines for the clinical application of echocardiography a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on clinical application of echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation. 95:1997;1686-1744
17. Starling M.R., Crawford M.H., Sorensen S.G., Levi B., Richards K.L., O'Rourke R.A. Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance. Circulation. 63:1981;1075-1084
18. Schiller N.B., Acquatella H., Ports T.A., Drew D., Goerke J., Ringertz H., Silverman N.H., Brundage B., Botvinick E.H., Boswell R., et al. Left ventricular volume from paired biplane 2-dimensional echocardiography. Circulation. 60:1979;547-555
19. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol. 57:1986;450-458
20. Tsuchihashi M., Tsutsui H., Kodama K., Kasagi F., Takeshita A. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure a study in Fukuoka, Japan. Jpn Circ J. 64:2000;953-959
21. Davidson N.C., Naas A.A., Hanson J.K., Kennedy N.S.J., Coutie W.J., Struthers A.D. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. J Am Coll Cardiol. 77:1996;828-831
22. Bettencourt P., Ferreira A., Dias P., Pimenta J., Frioes F., Martins L., Cerqueira-Gomes M. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail. 6:2000;306-313
23. Maeda K., Tsutamoto T., Wada A., Hisanaga T., Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 135:1998;825-832
24. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., Ohnishi M., Sugimoto Y., Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516
25. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Mabuchi N., Hayashi M., Ohnishi M., Sawaki M., Fujii M., Horie H., et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J. 20:1999;1799-1807